ES2245648T3 - Sistema de administracion transdermal que contiene clorhidrato de tulobuterol que permite la administracion del broncodilatador tulobuterol a traves de la piel. - Google Patents

Sistema de administracion transdermal que contiene clorhidrato de tulobuterol que permite la administracion del broncodilatador tulobuterol a traves de la piel.

Info

Publication number
ES2245648T3
ES2245648T3 ES00966123T ES00966123T ES2245648T3 ES 2245648 T3 ES2245648 T3 ES 2245648T3 ES 00966123 T ES00966123 T ES 00966123T ES 00966123 T ES00966123 T ES 00966123T ES 2245648 T3 ES2245648 T3 ES 2245648T3
Authority
ES
Spain
Prior art keywords
tulobuterol
delivery system
matrix
transdermal delivery
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00966123T
Other languages
English (en)
Spanish (es)
Inventor
Stefan Bracht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2245648T3 publication Critical patent/ES2245648T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES00966123T 1999-10-16 2000-10-06 Sistema de administracion transdermal que contiene clorhidrato de tulobuterol que permite la administracion del broncodilatador tulobuterol a traves de la piel. Expired - Lifetime ES2245648T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19950066 1999-10-16
DE19950066A DE19950066A1 (de) 1999-10-16 1999-10-16 Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut

Publications (1)

Publication Number Publication Date
ES2245648T3 true ES2245648T3 (es) 2006-01-16

Family

ID=7925993

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00966123T Expired - Lifetime ES2245648T3 (es) 1999-10-16 2000-10-06 Sistema de administracion transdermal que contiene clorhidrato de tulobuterol que permite la administracion del broncodilatador tulobuterol a traves de la piel.

Country Status (12)

Country Link
US (1) US7056528B1 (https=)
EP (1) EP1220662B1 (https=)
JP (2) JP4874486B2 (https=)
KR (1) KR101014074B1 (https=)
AR (1) AR026040A1 (https=)
AT (1) ATE299019T1 (https=)
AU (1) AU7662400A (https=)
CA (1) CA2387143C (https=)
DE (2) DE19950066A1 (https=)
ES (1) ES2245648T3 (https=)
PT (1) PT1220662E (https=)
WO (1) WO2001028531A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100469995B1 (ko) * 2002-05-20 2005-02-05 안국약품 주식회사 천식치료제를 함유한 매트릭스형 패취
WO2004112770A1 (ja) * 2003-06-20 2004-12-29 Teikoku Seiyaku Co., Ltd. ツロブテロール含有貼付剤
DE10340152B4 (de) 2003-09-01 2006-05-04 BÖCO Böddecker & Co. GmbH & Co. KG Schloß mit einer Drehfalle und einer Sperrklinke
CA2542778C (en) * 2003-10-28 2012-05-29 Noven Pharmaceuticals, Inc. Transdermal drug delivery composition
CN1297257C (zh) * 2004-01-02 2007-01-31 上海现代药物制剂工程研究中心有限公司 含有妥洛特罗的压敏胶，透皮贴剂及制备方法和应用
WO2006051818A1 (ja) * 2004-11-10 2006-05-18 Hisamitsu Pharmaceutical Co., Inc. 外用製剤及び貼付剤
EP1806151B1 (en) * 2004-11-10 2012-05-23 Hisamitsu Pharmaceutical Co., Inc. Drug for external use and adhesive patch
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
DE102004062614B4 (de) * 2004-12-24 2011-12-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit aktivierbarer Übersättigung und kontrollierter Permeationförderung sowie Verfahren zu dessen Herstellung
CA3172541C (en) * 2009-06-05 2026-04-14 Durr Systems, Inc. Improved infrared float bar
JP5766475B2 (ja) * 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
EP2688561B1 (en) * 2011-03-24 2018-08-22 Teikoku Pharma USA, Inc. Transdermal compositions comprising an active agent layer and an active agent conversion layer
JP5941466B2 (ja) * 2011-07-21 2016-06-29 帝國製薬株式会社 水性貼付剤
CN102552221B (zh) * 2012-01-11 2013-09-04 中国人民解放军军事医学科学院微生物流行病研究所 一种妥洛特罗贴剂及其制备方法
NZ628481A (en) * 2012-01-11 2016-11-25 Adelaide Res & Innovation Pty Stabilising and analysing fatty acids in a biological sample stored on solid media
AU2013338243B2 (en) 2012-11-02 2016-09-29 Teikoku Seiyaku Co., Ltd. Propynylaminoindan transdermal compositions
US9962349B2 (en) 2014-10-17 2018-05-08 Fidia Farmaceutici S.P.A. Dermal therapeutic system with high adhesivity
EP3395336A1 (en) 2017-04-28 2018-10-31 Nitto Denko Corporation Transdermal absorption preparation
CN109541065B (zh) * 2018-12-04 2019-10-01 山东大学 一种妥洛特罗贴剂的分析方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU578275B2 (en) * 1984-03-01 1988-10-20 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Pharmaceutical compositions
JPH0725669B2 (ja) 1988-12-23 1995-03-22 日東電工株式会社 経皮投与用医薬製剤
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
IT1251469B (it) 1991-07-15 1995-05-15 Zambon Spa Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante.
EP0593807A1 (en) * 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
ES2180546T3 (es) * 1992-07-23 2003-02-16 Hisamitsu Pharmaceutical Co Composicion basica administrable percutaneamente y composicion de farmaco preparada a partir de ella.
JP2753800B2 (ja) * 1994-04-14 1998-05-20 日東電工株式会社 経皮吸収型製剤
JP3466305B2 (ja) * 1994-12-12 2003-11-10 久光製薬株式会社 溶解剤および該溶解剤を含有する外用製剤
EP0943330A4 (en) * 1996-10-04 2001-08-16 Saitama Daiichi Seiyaku Kabush BAND AID
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
JP3930984B2 (ja) * 1997-12-12 2007-06-13 日東電工株式会社 経皮吸収型製剤
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof

Also Published As

Publication number Publication date
JP4874486B2 (ja) 2012-02-15
WO2001028531A1 (de) 2001-04-26
AU7662400A (en) 2001-04-30
AR026040A1 (es) 2002-12-26
DE19950066A1 (de) 2001-04-26
EP1220662B1 (de) 2005-07-06
JP2003528037A (ja) 2003-09-24
PT1220662E (pt) 2005-10-31
KR20020047240A (ko) 2002-06-21
EP1220662A1 (de) 2002-07-10
US7056528B1 (en) 2006-06-06
CA2387143C (en) 2009-06-02
DE50010679D1 (de) 2005-08-11
KR101014074B1 (ko) 2011-02-14
JP2011252003A (ja) 2011-12-15
ATE299019T1 (de) 2005-07-15
CA2387143A1 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
ES2245648T3 (es) Sistema de administracion transdermal que contiene clorhidrato de tulobuterol que permite la administracion del broncodilatador tulobuterol a traves de la piel.
US20250325496A1 (en) Sodium bicarbonate in situ conversion driven transdermal delivery of amine drug
ES2466647T3 (es) Preparación absorbible por vía transdérmica que comprende un agente contra la demencia
ES2270832T3 (es) Sistema terapeutico transdermico (tts) que contiene tolteridina.
ES2762460T3 (es) Composiciones y métodos de administración dérmica
ES2237104T3 (es) Dispositivo portador de productos farmaceuticos adecuado para el aporte de compuestos farmaceuticos a superficies mucosas.
EP0831827B1 (en) Novel formulations for transdermal delivery of pergolide
ES2407987T3 (es) Composición para la administración transdérmica de fentanilo
ES2396598T3 (es) Preparaciones en forma de suspensiones acuosas
CN1129427C (zh) 含抗氧剂的tts
ES2281641T3 (es) Sistema de administracion transdermica con dos capas adhesivas superpuestas que tienen diferente afinidad por la sustancia activa.
ES2377134T3 (es) Preparación tópica de enfriamiento en forma de parche
ES2386886T3 (es) Procedimiento para la producción de un sistema terapéutico transdermal altamente flexible con nicotina en calidad de principio activo
ES3001152T3 (es) Sistema terapéutico transdérmico que contiene asenapina y polisiloxano o poliisobutileno
KR101239150B1 (ko) 도네페질-함유 경피흡수제제 및 그의 제조방법
JP2006117688A (ja) オキシブチニンのためのモノグリセリド／乳酸エステル透過促進剤
PT100502A (pt) Composicoes farmaceuticas para aumentar a capacidade de permeacao na pele utilizando monolinoleato de glicerol
WO2011074636A1 (ja) 抗認知症薬物の経皮吸収製剤
ES2702879T3 (es) Composiciones de anfetamina transdérmicas estables y métodos de fabricación
ES2980467T3 (es) Sistema terapéutico transdérmico que contiene agomelatina
US20070202156A1 (en) Adhesive preparation comprising sufentanil and methods of using same
ES2897449T3 (es) Sistema terapéutico transdérmico transparente que contiene nicotina
US20090169603A1 (en) Adhesive Pharmaceutical Preparation
AU2021256454A1 (en) Transdermal and/or topical delivery system comprising hydroxychloroquine and/or chloroquine
ES2330653T3 (es) Dispositivo de administracion transdermica para antagonistas de calcio de tipo dihidropiridina que contienen al menos un acido graso.